Lexicon Pharmaceuticals Company Profile

Aggregated data from the web about Lexicon Pharmaceuticals

Company Name	Lexicon Pharmaceuticals
Website	www.lexpharma.com
Snippet	Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update Xermelo (Telotristat Ethyl) An orally-delivered small molecule compound that is approved for the treatment of carcinoid syndrome diarrhea.
Type	Public
Founded	1995
Website	www.lexpharma.com
Industry	Pharmaceutical
Traded as	NASDAQ: LXRX
Key people	Lonnel Coats, President and Chief Executive OfficerBrian P. Zambrowicz, EVP & Chief Scientific OfficerJeffrey L. Wade, EVP of Corporate Development & Chief Scientific OfficerAlan J. Main, EVP of Pharmaceutical ResearchPablo Lapuerta, EVP of Clinical Development & Chief Medical OfficerJames F. Tessmer, VP of Finance and Accounting
Headquarters	The Woodlands, United States
Number of employees	225 (2011)

Lexicon Pharmaceuticals is part of the United States company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.